Literature DB >> 21465480

Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils.

Ki-Young Lee1, Lijuan Liu, Yan Jin, Song-Bin Fu, Jesusa L Rosales.   

Abstract

Secretion by neutrophils contributes to acute inflammation following injury or infection. Vimentin has been shown to be important for secretion by neutrophils but little is known about its dynamics during secretion, which is regulated by cyclin-dependent kinase 5 (Cdk5). In this study, we sought to examine the vimentin dynamics and its potential regulation by Cdk5 during neutrophil secretion. We show that vimentin is a Cdk5 substrate that is specifically phosphorylated at Ser56. In response to neutrophil stimulation with GTP, vimentin Ser56 was phosphorylated and colocalized with Cdk5 in the cytoplasmic compartment. Vimentin pSer56 and Cdk5 colocalization was consistent with coimmunoprecipitation from stimulated cells. Vimentin Ser56 phosphorylation occurred immediately after stimulation, and a remarkable increase in phosphorylation was noted later in the secretory process. Decreased GTP-induced vimentin Ser56 phosphorylation and secretion resulted from inhibition of Cdk5 activity by roscovitine or olomoucine or by depletion of Cdk5 by siRNA, suggesting that GTP-induced Cdk5-mediated vimentin Ser56 phosphorylation may be related to GTP-induced Cdk5-mediated secretion by neutrophils. Indeed, inhibition of vimentin Ser56 phosphorylation led to a corresponding inhibition of GTP-induced secretion, indicating a link between these two events. While fMLP also induced vimentin Ser56 phosphorylation, such phosphorylation was unaffected by roscovitine, which nonetheless, inhibited secretion, suggesting that Cdk5 regulates fMLP-induced secretion via a mechanism independent of Cdk5-mediated vimentin Ser56 phosphorylation. These findings demonstrate the distinct involvement of Cdk5 in GTP- and fMLP-induced secretion by neutrophils, and support the notion that specific targeting of Cdk5 may serve to inhibit the neutrophil secretory process.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21465480      PMCID: PMC3855454          DOI: 10.1002/jcp.22782

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  50 in total

1.  Balance between activities of Rho kinase and type 1 protein phosphatase modulates turnover of phosphorylation and dynamics of desmin/vimentin filaments.

Authors:  H Inada; H Togashi; Y Nakamura; K Kaibuchi; K Nagata; M Inagaki
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  Association of protein phosphatase 2A with its substrate vimentin intermediate filaments in 9L rat brain tumor cells.

Authors:  T J Cheng; Y L Lin; A S Chiang; Y K Lai
Journal:  J Cell Biochem       Date:  2000-07-19       Impact factor: 4.429

3.  GTP-dependent permeabilized neutrophil secretion requires a freely diffusible cytosolic protein.

Authors:  J L Rosales; J D Ernst
Journal:  J Cell Biochem       Date:  2000-09-18       Impact factor: 4.429

Review 4.  The motility and dynamic properties of intermediate filaments and their constituent proteins.

Authors:  Ying-Hao Chou; Frederick W Flitney; Lynne Chang; Melissa Mendez; Boris Grin; Robert D Goldman
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

5.  Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.

Authors:  Yukio Azuma; Keiichi Kosaka; Masanori Kashimata
Journal:  Eur J Pharmacol       Date:  2007-05-22       Impact factor: 4.432

6.  Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway.

Authors:  Isabelle Ernens; Didier Rouy; Emilie Velot; Yvan Devaux; Daniel R Wagner
Journal:  Circ Res       Date:  2006-08-17       Impact factor: 17.367

7.  Vimentin in cultured chromaffin cells: an immunofluorescent, biochemical and functional study.

Authors:  J L Quintanar
Journal:  Cell Physiol Biochem       Date:  2000

Review 8.  A decade of CDK5.

Authors:  R Dhavan; L H Tsai
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

9.  The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis.

Authors:  Andrew E Leitch; Nicola A Riley; Tara A Sheldrake; Michela Festa; Sarah Fox; Rodger Duffin; Christopher Haslett; Adriano G Rossi
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

10.  Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.

Authors:  Adriano G Rossi; Deborah A Sawatzky; Annemieke Walker; Carol Ward; Tara A Sheldrake; Nicola A Riley; Alison Caldicott; Magdalena Martinez-Losa; Trevor R Walker; Rodger Duffin; Mohini Gray; Elvira Crescenzi; Morag C Martin; Hugh J Brady; John S Savill; Ian Dransfield; Christopher Haslett
Journal:  Nat Med       Date:  2006-09-03       Impact factor: 53.440

View more
  12 in total

1.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

2.  Molecular and biological characterization of Streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin.

Authors:  Laura M Icenogle; Shawna M Hengel; Lisette H Coye; Amber Streifel; Carleen M Collins; David R Goodlett; Steve L Moseley
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 3.  A curious case of cyclin-dependent kinases in neutrophils.

Authors:  Ramizah Syahirah; Alan Y Hsu; Qing Deng
Journal:  J Leukoc Biol       Date:  2022-02-21       Impact factor: 6.011

4.  Polo-like Kinase 1 Regulates Vimentin Phosphorylation at Ser-56 and Contraction in Smooth Muscle.

Authors:  Jia Li; Ruping Wang; Olivia J Gannon; Alyssa C Rezey; Sixin Jiang; Brennan D Gerlach; Guoning Liao; Dale D Tang
Journal:  J Biol Chem       Date:  2016-09-23       Impact factor: 5.157

5.  Targeting the cyclin-dependent kinase 5 in metastatic melanoma.

Authors:  Samanta Sharma; Tian Zhang; Wojciech Michowski; Vito W Rebecca; Min Xiao; Roberta Ferretti; Jan M Suski; Roderick T Bronson; Joao A Paulo; Dennie Frederick; Anne Fassl; Genevieve M Boland; Yan Geng; Jacqueline A Lees; Rene H Medema; Meenhard Herlyn; Steven P Gygi; Piotr Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-19       Impact factor: 11.205

6.  Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer.

Authors:  Xinyu Deng; Morris Kohanfars; Huan Ming Hsu; Puneet Souda; Joe Capri; Julian P Whitelegge; Helena R Chang
Journal:  Int J Proteomics       Date:  2014-11-13

7.  Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells.

Authors:  Martina Semelakova; Stèphane Grauzam; Prabhakar Betadthunga; Jessica Tiedeken; Sonya Coaxum; David M Neskey; Steven A Rosenzweig
Journal:  Transl Oncol       Date:  2018-09-26       Impact factor: 4.243

8.  Vimentin dephosphorylation at ser-56 is regulated by type 1 protein phosphatase in smooth muscle.

Authors:  Jia Li; Ruping Wang; Dale D Tang
Journal:  Respir Res       Date:  2016-07-25

9.  Neutrophil TLR4 and PKR are targets of breast cancer cell glycosaminoglycans and effectors of glycosaminoglycan-induced APRIL secretion.

Authors:  Uilst Bat-Erdene; Eric Quan; Kelvin Chan; Brianna-Marie Lee; Wejdan Matook; Ki-Young Lee; Jesusa L Rosales
Journal:  Oncogenesis       Date:  2018-06-15       Impact factor: 7.485

10.  Titanium Dioxide Nanoparticles Alter the Cellular Phosphoproteome in A549 Cells.

Authors:  Mathilde Biola-Clier; Jean-Charles Gaillard; Thierry Rabilloud; Jean Armengaud; Marie Carriere
Journal:  Nanomaterials (Basel)       Date:  2020-01-21       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.